Eli Lilly Institute for Genetic Medicine

Eli Lilly & Co. has developed a cutting-edge $700 million institute for genetic medicine located in Boston’s vibrant Seaport District. The institute, spanning 334,000 square feet and situated at 15 Necco St. within a 12-story healthcare and life sciences building, is poised to be a hub for groundbreaking research and innovation. Here, Lilly will focus on the development of genetic medicines targeting a variety of conditions, including diabetes, immunology, and central nervous system disorders. With a mission to propel promising discoveries from the laboratory to clinical trials and eventually to patients, the institute represents a significant step forward in Lilly’s commitment to advancing healthcare.

Designed to foster collaboration and creativity, the facility will feature a rooftop terrace adorned with green spaces and adaptable work environments. Moreover, the ground floor will host retail and dining options, creating a dynamic environment for both work and leisure. Nestled alongside a picturesque waterfront park complete with walking trails, art installations, and event spaces, the institute promises to be a beacon of scientific excellence in a vibrant urban setting.